Michael Cornelius
Director of Finance/CFO at TissueTech, Inc.
Profile
Michael Cornelius is the founder of Emunamedica LLC.
He currently works as the Chief Financial Officer at TissueTech, Inc. Previously, he worked as the Chief Financial Officer at Stiefel Laboratories, Inc.
Michael Cornelius active positions
Companies | Position | Start |
---|---|---|
TissueTech, Inc.
TissueTech, Inc. BiotechnologyHealth Technology TissueTech, Inc. develops and manufactures regenerative amniotic tissue-based products. Its products include aminiograft, prokera, cliradex, and neox. It serves ophthalmology, optometry, musculoskeletal, and wound care markets. The company was founded by Amy H. Tseng and Scheffer Tseng in 1997 and is headquartered in Miami, FL. | Director of Finance/CFO | - |
Former positions of Michael Cornelius
Companies | Position | End |
---|---|---|
Emunamedica LLC
Emunamedica LLC Medical/Nursing ServicesHealth Services Emunamedica LLC operates as a diagnostics company. It has developed a patented and clinically-tested system designed to assess whether a chronic wound, such as a diabetic foot ulcer will heal given the current course of therapy. The company was founded by David Kolb and Michael Cornelius and is headquartered in Hollywood, FL. | Founder | - |
Stiefel Laboratories, Inc.
Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Stiefel Laboratories, Inc. engages in the manufacture of pharmaceutical products. It offers prescription and non-prescription dermatological and skin care products. The firm research, innovate and develop skin care treatments to health care professionals, patients and consumers. The company was founded in 1847 and is headquartered in Research Triangle Park, NC. | Director of Finance/CFO | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Emunamedica LLC
Emunamedica LLC Medical/Nursing ServicesHealth Services Emunamedica LLC operates as a diagnostics company. It has developed a patented and clinically-tested system designed to assess whether a chronic wound, such as a diabetic foot ulcer will heal given the current course of therapy. The company was founded by David Kolb and Michael Cornelius and is headquartered in Hollywood, FL. | Health Services |
TissueTech, Inc.
TissueTech, Inc. BiotechnologyHealth Technology TissueTech, Inc. develops and manufactures regenerative amniotic tissue-based products. Its products include aminiograft, prokera, cliradex, and neox. It serves ophthalmology, optometry, musculoskeletal, and wound care markets. The company was founded by Amy H. Tseng and Scheffer Tseng in 1997 and is headquartered in Miami, FL. | Health Technology |
Stiefel Laboratories, Inc.
Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Stiefel Laboratories, Inc. engages in the manufacture of pharmaceutical products. It offers prescription and non-prescription dermatological and skin care products. The firm research, innovate and develop skin care treatments to health care professionals, patients and consumers. The company was founded in 1847 and is headquartered in Research Triangle Park, NC. | Health Technology |
- Stock Market
- Insiders
- Michael Cornelius